ScanSource (SCSC) Rides Digital Transformation Narrative On A Fair Value View Of $78

Simply Wall St · 3d ago

ScanSource (SCSC) has caught investor attention after recently closing at US$57.85, with the stock showing mixed short term moves yet a stronger pattern over the past 3 years.

Recent trading has been choppy, with a small 1-day share price return of 0.12% and a 7-day pullback of 1.09%. Even so, ScanSource still carries a 30-day share price gain of 1.33% and a 90-day share price return of 13.72%, while the 3-year total shareholder return of 87.46% may be of interest to long-term investors.

Scan for the next potential mover by comparing ScanSource with a curated 17 high quality undiscovered gems list that combines solid fundamentals with quieter share price stories.

ScanSource has already rewarded patient holders, yet the recent run to US$57.85 raises a sharper question: Does the current price still leave enough upside to justify the risk buyers would be taking on now?

Most Popular Narrative: 26% Undervalued

On the most followed view of ScanSource, a fair value of $78 sits well above the recent $57.85 close, which frames the current debate around whether the stock still offers an underappreciated opportunity for patient holders.

The accelerating enterprise shift toward digital transformation, converged IT solutions, and edge computing is driving sustained demand for integrated hardware, software, and services, allowing ScanSource to capture outsized wallet share and potentially elevate long-term revenue growth well above industry averages.

Operational transformation via automation of distribution centers and expanded use of data analytics will significantly reduce operating costs and unlock new revenue per customer opportunities, materially lifting operating margins and net income over time.

See why 2 investors see ScanSource as 26% undervalued.

Result: Fair Value of $78 (UNDERVALUED)

Still, if hardware commoditisation accelerates or key vendors push more sales directly to customers, the bullish ScanSource narrative could quickly lose momentum.

Find out about the key risks to this ScanSource narrative.

Next Steps

If this ScanSource story feels finely balanced between promise and risk, now is the moment to examine the details yourself and decide where you stand. To see both perspectives in one place, review the 3 key rewards and 1 important warning sign.

Ready for more ScanSource style ideas?

If the ScanSource narrative has you thinking bigger about your portfolio, do not stop here. Broaden your opportunity set with curated screeners built to surface quality, risk aware ideas before they hit everyone’s radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.